Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Tachycardia, Ventricular

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Tachycardia, Ventricular in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diffley, M1
Armenian, P1
Gerona, R1
Reinhartz, O1
Avasarala, K1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Tachycardia, Ventricular

ArticleYear
Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.
    Critical care medicine, 2012, Volume: 40, Issue:7

    Topics: Adolescent; Amino Acid Substitution; Hallucinogens; Heart Arrest; Humans; Intensive Care Units, Pedi

2012